In today's fiercely competitive landscape, it's becoming increasingly important for Pharma organisations to strategically partner with each other and across the wider healthcare ecosystem. By doing so, they can leverage their strengths, share risks, and unlock innovation, resulting in benefits that far exceed the sum of the individual parts.​

However, despite the potential advantages, many organisations grapple with how to effectively operate within a strategic partnership. Overcoming these challenges can lead to a range of benefits, from being perceived as an attractive innovative partner of choice, to navigating compliance in a more complex R&D setting, to achieving financial and scientific goals.​

To fully realise the potential of strategic partnerships and maximise health outcomes, organisations must act now to change the way they operate, both at an enterprise and partnership level.

Our Insights


Contribute to the discussion

We are running a survey to collect industry trends and perspectives on R&D strategic partnerships. If this is a space in which you have worked, please contribute your perspectives via the link below. The survey is anonymous, and we will share the results on our website over summer 2024.

Complete our survey


What's coming up?

Future topics and content in this series.

In depth R&D partnership case studies

Examples of building stronger strategic partnerships in R&D to leverage strengths, share risks, and unlock innovation.

Driving digital, data and technology innovation through strategic partnerships

We'll be sharing our insights later this year.

Utilising strategic partnerships to influence and impact the wider healthcare landscape

We'll be sharing our insights later this year.

Our Experts

Subscribe to our Pharmaceuticals and Life Sciences reports

The latest industry news and trending topics direct to your inbox.

Subscribe now

Contact us

Find out what we can do for you...

Get in touch